UnitedHealth Group is facing its first projected annual revenue decline since 1989, leading to a sharp stock drop of nearly 20%. Analysts from Piper Sandler and Morgan Stanley have lowered their price targets due to the company's forecasted revenue contraction in 2026, which compounds concerns about the impact of recent Medicare rate proposals. Despite a better-than-expected earnings report, operational improvements have been overshadowed by ongoing risks, resulting in a significant loss of approximately $60 billion in market value.
“Piper Sandler analyst Jessica Tassan · remains bullish on · UnitedHealth (UNH) stock · true”
“Piper Sandler analyst Jessica Tassan · lowered her price target on · UNH stock · $396 from $417”
“Piper Sandler analyst Jessica Tassan · keeps an · Overweight rating on UNH · true”
“NYSE:UNH · is preparing for · first projected annual revenue decline · since 1989”
“UnitedHealth Group Incorporated (NYSE:UNH) · is included among · the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds”
“Morgan Stanley analyst Erin Wright · trimmed her price target on · UnitedHealth Group Incorporated (NYSE:UNH) · $409 from $411”
“UnitedHealth Group Incorporated (NYSE:UNH) · is the parent of · the largest private health insurer in the US”
“UnitedHealth Group Inc. · volume · stock · 8,476,227”
“Berkshire Hathaway · purchased · 5,039,564 UNH shares · in the second quarter”
“Berkshire Hathaway · bought UNH stock at a price between · $248.88 and $606.36 per share”
“UnitedHealth · reported earnings per share of · $2.11”
“UnitedHealth · reported revenue of · $113.22 billion”
